🔔 Stock Mornings← All issues
Nasdaq 26,550 Β· GDP and inflation data due today; could shape December rate outlook ‌ ‌ ‌ ‌ ‌
🔔
Stock Mornings
Your weekday pre-market read on US stocks.
Issue #92 Β· Thursday, October 29, 2026
Volatility (VIX)  Cautious Β· 17.0  β–² from 16.9 yesterday
Small gains across major indexes mask mixed corporate results and incoming economic data that could influence Fed rate decisions.
 
 

●  The Numbers

S&P 5007,743.98  +0.28%
-0.17% this week
Nasdaq Composite26,549.85  +0.27%
-0.57% this week
Dow Jones52,475.10  +0.19%
-0.72% this week
Russell 20002,830.51  +0.41%
+1.78% this week

Before the bell: see how Asia, Europe & US futures traded overnight →

●  The Movers

Leaders

GOOGL Alphabet+1.34%
AMZN Amazon+0.59%
^RUT Russell 2000+0.41%

Laggards

SPCX SpaceX-2.25%
META Meta-1.24%
NVDA Nvidia-1.17%

The day's best and worst of the tracked indices and mega-caps Β· day-over-day change.

●  The Read

S&P 500 β€” description, not prediction

Trading above both its 50-day (7,698.05) and 200-day (7,302.71) averages β€” the longer-term trend reads as up. 30-day range 7,623.68–7,818.93; currently in the middle third of that range. RSI(14) 48 β€” momentum roughly neutral.

See where every market sits on the daily page β†’

●  The Brief

 GDP and inflation data due today; could shape December rate outlook

Economic reports arriving at 8:30 a.m. ET will show growth and price pressures. Strong results could increase likelihood of another interest-rate increase from the Federal Reserve. (MarketWatch)

 Merck beats estimates, raises outlook on Keytruda immunotherapy strength

Pharmaceutical giant Merck reported quarterly earnings above expectations and lifted full-year profit guidance, driven by stronger-than-expected sales of its cancer drug Keytruda. (CNBC)

 Eli Lilly surges past estimates on obesity and diabetes drug demand

Eli Lilly raised sales outlook after obesity drug Zepbound and diabetes treatment Mounjaro posted surging third-quarter sales, continuing market dominance in weight-loss medications. (CNBC)

 Alphabet earnings miss signals AI competition pressure on search revenue

Google parent company Alphabet missed earnings expectations with weaker-than-expected core search revenue, suggesting artificial intelligence competition is beginning to impact its primary business. (CNBC)

Partner

The charts we read every morning

TradingView is the charting platform a lot of "The Read" leans on β€” live charts, screeners and alerts for stocks, indexes and the VIX. New to it? This link puts toward a paid plan.

Try TradingView β†’

Markets 101

What is the VIX?

A real-time index of how much volatility the market expects in the S&P 500 over the next 30 days. High VIX = fear and big expected swings; low VIX = calm. It describes mood β€” it doesn't predict direction.

β€œMarkets are a description of today, not a forecast of tomorrow.”

Stock Mornings is an educational digest for US readers. Nothing here is financial, investment, tax, or legal advice. Stocks carry risk β€” you can lose money, and past performance does not predict future results. Some links may be affiliate links; we may earn a commission at no cost to you. Prices via Yahoo Finance, captured shortly before the opening bell.

Forwarded this email? Get your own free β†’

Part of the Mornings family from SolutionC LLC  ·  Gold Mornings  ·  Coin Mornings  ·  ▶ YouTube

stockmornings.com

← All issues  ·  stockmornings.com